Oral GLP-1 pill shows major weight loss, blood sugar control in trial
This digest was compiled by AI from multiple sources — links to the originals are below.
A new oral GLP-1 medication helped people with type 2 diabetes dramatically improve blood sugar control and lose weight in a major clinical trial. The results suggest that highly effective diabetes treatments may soon become available in a much more convenient pill form.
The Trial Results
The clinical trial enrolled over 2,000 participants with type 2 diabetes across 150 sites worldwide. Patients taking the oral GLP-1 pill achieved an average weight loss of 12.5% of body weight and a 1.8% reduction in HbA1c levels over 68 weeks. The placebo group saw only 2.3% weight loss and 0.4% HbA1c reduction.
Mechanism and Convenience
The pill mimics the GLP-1 hormone, which stimulates insulin secretion and reduces appetite. Unlike injectable GLP-1 drugs such as semaglutide, the oral formulation does not require refrigeration or injection training. Researchers noted that 89% of participants completed the trial, indicating high tolerability.
Regulatory Path
The drug developer plans to submit a New Drug Application to the U.S. FDA by Q4 2026. If approved, it would be the first oral GLP-1 therapy for type 2 diabetes with weight loss efficacy comparable to injectables. Analysts estimate peak annual sales could exceed $10 billion.
FDA Approval and Market Launch
The U.S. Food and Drug Administration approved Eli Lilly's oral GLP-1 pill Foundayo on Wednesday. The drug is set to hit the market next week, following the approval of Novo Nordisk's Wegovy pill.
Active Ingredient Confirmation
The Wegovy pill contains semaglutide, the same active ingredient as the injectable Wegovy and Ozempic. This confirms the oral formulation is a direct tablet version of the existing GLP-1 receptor agonist.
What's Next
The FDA is expected to review the application within 10 months of submission. It remains unclear whether the pill will be covered by insurance plans or face pricing scrutiny.
3 sources
Oral GLP-1 pill shows major weight loss, blood sugar control in trial
